ABBV vs. INVA
ABBV (AbbVie Inc.) and INVA (Innoviva, Inc.) are both stocks. Both are in the Healthcare sector — ABBV in Drug Manufacturers - General, INVA in Biotechnology. Over the past 10 years, ABBV returned 18.63%/yr vs 7.00%/yr for INVA. At a 0.26 correlation, their price movements are largely independent.
Performance
ABBV vs. INVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABBV achieves a -0.77% return, which is significantly lower than INVA's 11.71% return. Over the past 10 years, ABBV has outperformed INVA with an annualized return of 18.63%, while INVA has yielded a comparatively lower 7.00% annualized return.
ABBV
- 1D
- -1.83%
- 1M
- 10.68%
- YTD
- -0.77%
- 6M
- 1.62%
- 1Y
- 21.34%
- 3Y*
- 21.59%
- 5Y*
- 18.74%
- 10Y*
- 18.63%
INVA
- 1D
- -0.84%
- 1M
- -2.45%
- YTD
- 11.71%
- 6M
- 6.33%
- 1Y
- 3.48%
- 3Y*
- 18.85%
- 5Y*
- 12.47%
- 10Y*
- 7.00%
ABBV vs. INVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | -0.77% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
INVA Innoviva, Inc. | 11.71% | 15.22% | 8.17% | 21.06% | -23.19% | 39.23% | -12.50% | -18.85% | 22.97% | 32.62% |
Correlation
The correlation between ABBV and INVA is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013 | 0.26 |
The correlation between ABBV and INVA shifts across timeframes, from 0.15 (1 year) to 0.26 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ABBV:
$395.73B
INVA:
$1.89B
ABBV:
$2.05
INVA:
$5.94
ABBV:
108.68
INVA:
3.76
ABBV:
6.30
INVA:
4.47
ABBV:
14.39
INVA:
1.31
ABBV:
$62.82B
INVA:
$424.12M
ABBV:
$46.15B
INVA:
$323.16M
ABBV:
$17.96B
INVA:
$438.91M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABBV vs. INVA — Risk / Return Rank
ABBV
INVA
ABBV vs. INVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Innoviva, Inc. (INVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABBV | INVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.76 | ||
| Sortino ratioReturn per unit of downside risk | +0.93 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.05 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 1.24 | 0.15 | +1.09 |
| Martin ratioReturn relative to average drawdown | 2.77 | 0.34 | +2.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ABBV | INVA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.88 | 0.12 | +0.76 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.82 | 0.46 | +0.36 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.73 | 0.21 | +0.52 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.74 | 0.05 | +0.69 |
Drawdowns
ABBV vs. INVA - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum INVA drawdown of -84.32%. Use the drawdown chart below to compare losses from any high point for ABBV and INVA.
Loading charts...
Drawdown Indicators
| ABBV | INVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.09% | -84.32% | +39.23% |
Max Drawdown (1Y)Largest decline over 1 year | -17.32% | -23.53% | +6.21% |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | -23.53% | +2.79% |
Max Drawdown (5Y)Largest decline over 5 years | -21.92% | -47.01% | +25.09% |
Max Drawdown (10Y)Largest decline over 10 years | -45.09% | -59.57% | +14.48% |
Current DrawdownCurrent decline from peak | -6.55% | -30.17% | +23.62% |
Average DrawdownAverage peak-to-trough decline | -10.72% | -44.65% | +33.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.72% | 10.21% | -2.49% |
Volatility
ABBV vs. INVA - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 6.39%, while Innoviva, Inc. (INVA) has a volatility of 7.62%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than INVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABBV | INVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.39% | 7.62% | -1.23% |
Volatility (6M)Calculated over the trailing 6-month period | 17.89% | 16.91% | +0.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.33% | 28.81% | -4.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.91% | 27.28% | -4.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.74% | 33.89% | -8.15% |
Dividends
ABBV vs. INVA - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.02%, while INVA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.02% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
INVA Innoviva, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.12% |
Financials
ABBV vs. INVA - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Innoviva, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ABBV and INVA have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INVA has higher volatility (7.62%) compared to ABBV (6.39%). In terms of maximum drawdown, ABBV dropped -45.09% vs INVA's -84.32%.
ABBV currently has the higher Sharpe Ratio (0.88 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABBV and INVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer